Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

OCUL – Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc.
OCUL
$8.86
Name : Ocular Therapeutix, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,928,749,056.00
EPSttm : -1.42
finviz dynamic chart for OCUL
Ocular Therapeutix, Inc.
$8.86
0.80%
$0.07
OCUL — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

12.8

Margin Of Safety %

Put/Call OI Ratio

0.52

EPS Next Q Diff

-0.05

EPS Last/This Y

0.02

EPS This/Next Y

0.14

Price

8.85

Target Price

26.17

Analyst Recom

1.08

Performance Q

-21.31

Upside

-311.3%

Beta

0.92

Ticker: OCUL



17 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-17OCUL8.660.810.39168474
2026-03-18OCUL8.510.800.14168790
2026-03-19OCUL8.260.800.24167975
2026-03-20OCUL8.180.750.36163945
2026-03-23OCUL8.10.600.0275725
2026-03-24OCUL8.110.580.0977553
2026-03-25OCUL8.350.560.0579057
2026-03-26OCUL8.060.560.1379510
2026-03-27OCUL7.570.550.3280577
2026-03-30OCUL7.390.560.0479735
2026-03-31OCUL8.480.540.0581289
2026-04-01OCUL8.330.510.1584708
2026-04-02OCUL8.50.500.2386436
2026-04-06OCUL8.090.521.3584294
2026-04-08OCUL8.440.530.2085993
2026-04-09OCUL9.310.530.3086222
2026-04-13OCUL8.860.520.1284746
DateSymbolLatestP/C OIP/C VolTotal OI
17 items Current Page1 of 1



18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-17OCUL8.6615.4- -1.40
2026-03-18OCUL8.5115.4- -1.40
2026-03-19OCUL8.2715.4- -1.40
2026-03-20OCUL8.1815.4- -1.40
2026-03-23OCUL8.1015.4- -1.40
2026-03-24OCUL8.1115.4- -1.40
2026-03-25OCUL8.3515.4- -1.40
2026-03-26OCUL8.0615.4- -1.40
2026-03-27OCUL7.5715.4- -1.40
2026-03-30OCUL7.3915.4- -1.40
2026-03-31OCUL8.4815.4- -1.40
2026-04-01OCUL8.3415.4- -1.40
2026-04-02OCUL8.5115.4- -1.40
2026-04-06OCUL8.0915.4- -1.40
2026-04-07OCUL8.3315.4- -1.40
2026-04-09OCUL9.3015.4- -1.40
2026-04-10OCUL8.7915.4- -1.40
2026-04-13OCUL8.8515.4- -1.40
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-17OCUL-1.054.358.96
2026-03-18OCUL-1.054.358.96
2026-03-19OCUL-1.054.358.96
2026-03-20OCUL-1.054.358.96
2026-03-23OCUL-1.054.368.96
2026-03-24OCUL-1.054.368.96
2026-03-25OCUL-1.054.3612.03
2026-03-26OCUL-1.054.3612.03
2026-03-27OCUL-1.054.3612.03
2026-03-30OCUL-1.054.3512.03
2026-03-31OCUL-1.054.3512.03
2026-04-01OCUL-1.054.3512.03
2026-04-02OCUL-1.054.3512.03
2026-04-06OCUL-1.054.3312.03
2026-04-07OCUL-0.964.3312.03
2026-04-08OCUL-0.964.3312.03
2026-04-09OCUL-0.964.3312.03
2026-04-10OCUL-0.964.3312.03
2026-04-13OCUL-0.914.3112.80
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-0.29

Avg. EPS Est. Current Quarter

-0.32

Avg. EPS Est. Next Quarter

-0.34

Insider Transactions

-0.91

Institutional Transactions

4.31

Beta

0.92

Average Sales Estimate Current Quarter

12

Average Sales Estimate Next Quarter

13

Fair Value

Quality Score

44

Growth Score

38

Sentiment Score

46

Actual DrawDown %

55.4

Max Drawdown 5-Year %

-89.1

Target Price

26.17

P/E

Forward P/E

PEG

P/S

37.13

P/B

2.92

P/Free Cash Flow

EPS

-1.44

Average EPS Est. Cur. Y​

-1.4

EPS Next Y. (Est.)

-1.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-511.9

Relative Volume

0.45

Return on Equity vs Sector %

-68

Return on Equity vs Industry %

-51.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

◆ OCUL Healthcare
$8.86
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
9/25
Volume
11/15
Valuation
12/20
TP/AR
4/10
Options
7/10
RSI
52.1
Range 1M
78.5%
Sup Dist
5.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
26 /100
WEAK
Momentum
2/25
Growth
9/30
Estimates
3/20
Inst/Vol
5/15
Options
7/10
EPS Yr
5.5%
EPS NY
5.9%
52W%
27%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +195.4% upside
Quality
6/30
Valuation
15/30
Growth
6/25
Stability
9/10
LT Trend
1/5
Upside
+195.4%
Quality
44
Click a card to see score breakdown Full Analysis →
Ocular Therapeutix, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 325
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
OCUL

Latest News

—
Caricamento notizie per OCUL…
stock quote shares OCUL – Ocular Therapeutix, Inc. Stock Price stock today
news today OCUL – Ocular Therapeutix, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OCUL – Ocular Therapeutix, Inc. yahoo finance google finance
stock history OCUL – Ocular Therapeutix, Inc. invest stock market
stock prices OCUL premarket after hours
ticker OCUL fair value insiders trading